About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company at the forefront of transforming treatments for central nervous system (CNS) disorders. We excel in delivering innovative scientific solutions by pinpointing critical healthcare gaps and creating unique products with a focus on groundbreaking mechanisms of action that significantly enhance patient outcomes. Our prestigious neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, and migraine, alongside multiple late-stage development programs targeting a wide range of serious neurological and psychiatric diseases affecting over 150 million individuals across the United States. Our mission is to tackle some of the most pressing challenges of brain health, enabling patients and their families to thrive.

